Surgical Sectioning for Tethered Cord Syndrome
(OCCULT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether surgery is more effective than medicine for treating Occult Tethered Cord Syndrome (OTCS), a condition where the spinal cord is abnormally attached, causing pain and other issues. The main treatment under evaluation is a surgery called "Release of filum terminale," which releases fibrous tissue at the end of the spinal cord to determine if it more effectively relieves symptoms. Participants will either undergo the surgery or continue with medical management to compare results. Ideal candidates have experienced symptoms that have not improved with medicine for at least a year and have been diagnosed with OTCS. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the surgical sectioning for tethered cord syndrome is safe?
Research has shown that surgery to release the filum terminale, a tissue strand at the end of the spinal cord, is generally safe for treating tethered cord syndrome. Studies have found that this surgery effectively improves symptoms for most patients, with many experiencing significant relief.
Most surgeries yield good results with few complications. However, the procedure carries a risk of injuring nearby nerves. Despite this risk, careful monitoring during surgery helps reduce potential harm. Overall, patients generally tolerate the surgery well, and the benefits often outweigh the risks.12345Why do researchers think this study treatment might be promising?
Researchers are excited about the release of the filum terminale for tethered cord syndrome because it offers a direct surgical approach to alleviate tension on the spinal cord. Unlike standard treatments, which often focus on symptomatic relief or less invasive monitoring, this surgical method aims to directly address the root cause of the syndrome by cutting the filum terminale, a fibrous band that can restrict spinal cord movement. This approach could potentially provide more lasting relief from symptoms and improve quality of life for patients.
What evidence suggests that surgical sectioning is effective for Occult Tethered Cord Syndrome?
Research has shown that surgery to release the filum terminale can effectively treat tethered cord syndrome. In this trial, participants may undergo this surgical procedure. Studies have found that patients who underwent this surgery often experienced significant relief from their symptoms, especially those related to hypermobile Ehlers-Danlos syndrome (hEDS). Previous research suggests that surgery might be more effective than medication alone in managing symptoms of occult tethered cord syndrome (OTCS). This type of surgery is generally considered safe and offers a promising option for people with OTCS.12367
Who Is on the Research Team?
Jeffrey Greenfield, MD, PhD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for people aged 2 to 79 with Occult Tethered Cord Syndrome (OTCS) who haven't improved after at least a year of medical treatment. They must score at least 30 on the OCCULT Grading Scale. It's not for those with visible signs of spinal issues, previous lumbar spine or spinal dysraphism surgeries, or a history of central nervous system infections or autoimmune diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either surgical untethering of the filum terminale or medical management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Crossover
Subjects in the medical management arm may cross over to the surgical arm if deemed beneficial
What Are the Treatments Tested in This Trial?
Interventions
- Release of filum terminale
Release of filum terminale is already approved in United States, European Union for the following indications:
- Occult Tethered Cord Syndrome (OTCS)
- Symptomatic relief for OTCS patients
- Occult Tethered Cord Syndrome (OTCS)
- Symptomatic relief for OTCS patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor